Evidence map›Paper›PMID 35461036›Full record

ArticleThrombosis research2022

Comparison of IMPROVE, modified IMPROVE, IMPROVEDD, Padua and CHA2DS2-VASC risk scores for venous and arterial thrombotic events prediction in hospitalized COVID-19 patients.

Marko Lucijanic, Ivana Jurin, Martina Sedinic Lacko, Ena Soric, Anica Sabljic, Ivan Krecak, Josko Mitrovic, Daniela Marelic, Zvonimir Kremer, Irzal Hadzibegovic and 2 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Thrombosis research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Marko LucijanicHematology Department, University hospital Dubrava, Zagreb, Croatia; University of Zagreb School of Medicine, Zagreb, Croatia. Electronic address: markolucijanic@yahoo.com.
Ivana JurinCardiology Department, University hospital Dubrava, Zagreb, Croatia.
Martina Sedinic LackoHematology Department, University hospital Dubrava, Zagreb, Croatia.
Ena SoricHematology Department, University hospital Dubrava, Zagreb, Croatia.
Anica SabljicHematology Department, University hospital Dubrava, Zagreb, Croatia.
Ivan KrecakInternal Medicine Department, General Hospital Sibenik-Knin County, Sibenik, Croatia.
Josko MitrovicUniversity of Zagreb School of Medicine, Zagreb, Croatia; Clinical Immunology, Allergology and Rheumatology Department, University hospital Dubrava, Zagreb, Croatia.
Daniela MarelicUniversity of Zagreb School of Medicine, Zagreb, Croatia.
Zvonimir KremerUniversity of Zagreb School of Medicine, Zagreb, Croatia.
Irzal HadzibegovicCardiology Department, University hospital Dubrava, Zagreb, Croatia; Faculty of Dental Medicine and Health Care, Josip Juraj Strossmayer University, Osijek, Croatia.
Tomo LucijanicEndocrinology Department, University hospital Dubrava, Zagreb, Croatia.
Rajko KusecHematology Department, University hospital Dubrava, Zagreb, Croatia; University of Zagreb School of Medicine, Zagreb, Croatia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19ThrombosisHumansRetrospective StudiesRisk AssessmentRisk FactorsSARS-CoV-2CoagulopathySARS-CoV-2ThromboprophylaxisThrombosis

Identifiers

PMID35461036
PMCPMC9013703

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.